BioSpace News Archive

Cybin Inc. today announced positive preclinical data from a pharmacokinetic study evaluating its proprietary deuterated dimethyltryptamine (DMT) molecule, CYB004, delivered via inhalation.

Moderna, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, May 4, 2022 to report its first quarter 2022 financial results, and provide a corporate update.

Biomica Ltd. reported today that it signed a collaboration agreement with the Sheba Medical Center (Sheba) in Tel Aviv, Israel, a hospital ranked by Newsweek magazine as one of the top 10 globally of 2022[1].

Sampling Human, an early stage, life science technology company that has developed a diagnostic platform that harnesses genetically engineered cells to analyze other cells in their environment, has raised $2 million led by the venture capital firm i&i Biotech Fund (i&i Bio). Longevitytech.fund and Formic Ventures also participated in the recent financing.

The demand within the global invisible orthodontics market is set to rise at a boisterous pace in the years to follow.

Albany NY, United States: Synovial sarcoma is a predominantly juxta-articular, malignant, and soft-tissue tumour, which represents approximately 10% of all soft-tissue sarcomas.

Santhera Pharmaceuticals announces the appointment ofShabir Hasham, MD,as Chief Medical Officer and a member of Santhera’s Executive Management team, effective May 1, 2022.

International medical imaging IT and cybersecurity company Sectra has signed a contract with North York General Hospital in Canada.

Versantis announced that Innosuisse, the Swiss national innovation agency, will co-fund a project to develop a prototype portable point-of-care device for blood ammonia monitoring.

Collaboration Supports Companies’ Joint Focus on Medication Adherence and Affordability.